Benzinga | May 4, 2021 04:09PM EDT

Atara Biotherapeutics Q1 EPS $(0.86) Beats $(0.92) Estimate, Sales $3.55M Beat $1.60M Estimate

Atara Biotherapeutics (NASDAQ:ATRA) reported quarterly losses of $(0.86) per share which beat the analyst consensus estimate of $(0.92) by 6.52 percent. This is a 28.33 percent increase over losses of $(1.20) per share from the same period last year. The company reported quarterly sales of $3.55 million which beat the analyst consensus estimate of $1.60 million by 121.88 percent.